Incidence of contralateral cervical metastasis in laryngeal tumors
Arthur Paredes Gatti, Juliana Cristina Pacheco, Nicolas Galat Ahumada, Carlos Neutzling Lehn, Fernando Walder
Introduction: Through the knowledge of the metastatic pathways of the Squamous Cell Carcinoma (SCC) of the larynx, the lymph node level with a higher probability of involvement can be predicted. The surgeon uses this knowledge to determine the extension of neck dissection to perform. However, the longer the surgery, the greater the morbidity for the patient. When the metastatic risk is >20%, neck dissection of that cervical level is necessary. In cases of clinically evident (cN+) metastasis, uni or bilaterally, comprehensive neck dissection is determinant for the treatment, however there is no consensus about neck dissection for contralateral clinically negative neck (cN-). Objective: To evaluate if patients with laryngeal SCC homolateral cN+ and contralateral cN- should be submitted to bilateral neck dissection. Methods: The team reviewed medical records from 135 patients with a diagnosis of laryngeal malignancy between March/2009 and September/2017, analyzing gender, age, tobacco and alcohol comsumption, primary tumor site, neck dissection laterality, clinical and pathological contralaterality, staging, tumor recurrence or late metastasis and survival Results: We observed that 40.74% were pN+ on at least one side after neck dissection, which 87.27% performed bilateral neck dissection. Of these, 66.67% did not have contralateral metastasis, 87.5% had no previously clinically evident metastasis. Conclusion: Patients contralateral cN- have a risk <20% for occult metastasis and should not routinely go through bilateral neck dissection.
1. Patel KN, Shah JP. Neck dissection: past, present, future. Surg Oncol Clin N Am. 2005;14(3):461-77. http://dx.doi.org/10.1016/j.soc.2005.04.003. PMid:15978424.
2. Chan JY; Wei WI. Current management strategy of hypopharyngeal carcinoma. Auris Nasus Larynx. 2013;40(1):2-6.
3. Thawley SE, Panje WR, Batsakis JG, Lindberg RD. Comprehensive management of head and neck tumors. 2. ed. Filadélfia: W.B. Saunders; 1999.
4. Lauchlan DT, McCaul JÁ, McCarron T. Neck dissection and the clinical appearance of post-operative shoulder disability: the post-operative role of phisioterapy. Eur J Cancer Care. 2008;17(6):542-8. http://dx.doi.org/10.1111/j.1365- 2354.2007.00862.x. PMid:18793319.
5. Dünne AA, Budach VG, Wagner W, Werner JA. Management of N0 Neck in head and neck cancer: current controversies. Onkologie. 2004;27(4):363-7. PMid:15347891.
6. Gavilán C, Gavilán J. Five-year results of functional neck dissection for cancer of the larynx. Arch Otolaryngol Head Neck Surg. 1989;115(10):1193-6. http://dx.doi.org/10.1001/archotol.1989.01860340047015. PMid:2789774.
7. Zuo JJ, Tao ZZ, Chen C, Hu ZW, Xu YX, Zheng AY, Guo Y. Characteristics of cigarette smoking without alcohol consumption and laryngeal cancer: overall and time-risk relation. A meta-analysis of observational studies. Eur Arch Otorhinolaryngol. 2017;274(3):1617-31. http://dx.doi.org/10.1007/s00405-016- 4390-x. PMid:27844225.
8. Fiorella R, Di Nicola V, Fiorella ML, Russo C. “Conditional” neck dissection in management of laryngeal carcinoma. Acta Otorhinolaryngol Ital. 2006;26(6):356-9. PMid:17633155.
9. Amar A, Dedivitis RA, Rapoport A, Quarteiro AL. Indication of elective contralateral neck dissection in squamous cell carcinoma of the hypopharynx. Rev Bras Otorrinolaringol (Engl Ed). 2009;75(4):493-6. http://dx.doi.org/10.1016/S1808-8694(15)30485-7. PMid:19784415.
10. Liu YH, Du ZW. Management of clinically negative nodes (N0) in supraglottic laryngeal carcinoma: A systematic review. Genet Mol Res. 2016;15(4)
11. Böttcher A, Olze H, Thieme N, Stromberger C, Sander S, Münscher A, Bier J, Knopke S. A novel classification scheme for advanced laryngeal cancer midline involvement: implications for the contralateral neck. J Cancer Res Clin Oncol. 2017;143(8):1605-12. http://dx.doi.org/10.1007/s00432-017-2419-1. PMid:28396948.